T2	Concept 43 51	SARS-CoV
T3	Concept 58 66	proteins
T4	Concept 16 27;28 38	recombinant SARS-CoV-2
T1	Concept 52 57	spike
R1	has-property Arg1:T3 Arg2:T1	
T5	Concept 70 86	recombinant ACE2
T6	Concept 87 94	protein
T7	Concept 99 103	ACE2
T8	Concept 115 119	293T
T9	Concept 120 125	cells
R2	in-context Arg1:T8 Arg2:T9	
T10	Action 126 135	confirmed
T11	Concept 159 166	similar
T12	Action 167 174	binding
T14	Concept 195 199	ACE2
T15	Concept 189 194	human
R5	has-property Arg1:T14 Arg2:T15	
R6	in-context Arg1:T11 Arg2:T14	
T16	Concept 0 12	Measurements
R7	in-context Arg1:T3 Arg2:T2	
T17	Concept 58 66	proteins
R8	has-property Arg1:T17 Arg2:T1	
R9	in-context Arg1:T17 Arg2:T4	
R10	is-a Arg1:T5 Arg2:T6	
R11	is-a Arg1:T7 Arg2:T6	
T18	Action 104 114	expressing
R14	target Arg1:T18 Arg2:T8	
R15	subject Arg1:T10 Arg2:T18	
R16	in-context Arg1:T16 Arg2:T17	
R17	is-a Arg1:T16 Arg2:T3	
R12	subject Arg1:T18 Arg2:T16	
R13	in-context Arg1:T16 Arg2:T5	
R18	in-context Arg1:T16 Arg2:T7	
T19	Concept 28 38	SARS-CoV-2
T20	Concept 43 51	SARS-CoV
T21	Concept 144 157	coronaviruses
R19	is-a Arg1:T19 Arg2:T21	
R20	is-a Arg1:T20 Arg2:T21	
R3	has-property Arg1:T12 Arg2:T11	
R4	subject Arg1:T12 Arg2:T19	
R21	target Arg1:T10 Arg2:T12	
R22	subject Arg1:T12 Arg2:T20	
T13	Concept 325 335	SARS-CoV-2
T22	Concept 336 347	coronavirus
R23	is-a Arg1:T13 Arg2:T22	
T23	Concept 380 388	SARS-CoV
R24	is-a Arg1:T23 Arg2:T22	
T24	Concept 352 359	similar
T25	Action 360 376	transmissibility
R25	has-property Arg1:T25 Arg2:T24	
R26	in-context Arg1:T24 Arg2:T23	
R27	subject Arg1:T25 Arg2:T13	
T26	Action 288 295	explain
R28	target Arg1:T26 Arg2:T25	
R29	subject Arg1:T26 Arg2:T12	
T27	Action 408 418	enrichment
T28	Concept 422 429	glycine
T29	Concept 435 441	serine
T30	Concept 458 487	acidic residues glutamic acid
T31	Concept 496 509	aspartic acid
T32	Concept 431 432	G
T33	Concept 443 444	S
T34	Concept 489 490	E
T35	Concept 511 512	D
*	same-as T28 T32
*	same-as T29 T33
*	same-as T30 T34
*	same-as T31 T35
T36	Concept 526 534	compared
T37	Concept 542 558	original library
R30	in-context Arg1:T27 Arg2:T28	
R31	in-context Arg1:T27 Arg2:T29	
R32	in-context Arg1:T27 Arg2:T30	
R33	in-context Arg1:T27 Arg2:T31	
R34	has-property Arg1:T27 Arg2:T36	
R35	in-context Arg1:T36 Arg2:T37	
T40	Concept 636 646	Tupanvirus
T41	Concept 608 613	after
T42	Action 692 700	decrease
T43	Concept 652 658	amount
T44	Concept 662 668	mutant
T45	Concept 669 676;677 680	Guarani DNA
R36	has-property Arg1:T45 Arg2:T44	
R37	in-context Arg1:T43 Arg2:T45	
R38	subject Arg1:T42 Arg2:T43	
T38	Concept 622 630	passages
T39	Concept 614 621	several
R39	has-property Arg1:T38 Arg2:T39	
R40	in-context Arg1:T38 Arg2:T40	
R41	in-context Arg1:T41 Arg2:T38	
R42	in-time Arg1:T42 Arg2:T41	
T46	Concept 706 712	CTD 4A
T47	Concept 717 723	CTD 4E
T48	Concept 753 759	O-MAD2
T49	Concept 764 770	C-MAD2
T50	Action 742 749	binding
T51	Concept 731 738	defects
R43	has-property Arg1:T50 Arg2:T51	
R44	target Arg1:T50 Arg2:T48	
R45	target Arg1:T50 Arg2:T49	
T52	Action 742 749	binding
R46	has-property Arg1:T52 Arg2:T51	
R47	target Arg1:T52 Arg2:T48	
R48	target Arg1:T52 Arg2:T49	
R49	subject Arg1:T52 Arg2:T47	
R50	subject Arg1:T50 Arg2:T46	
T53	Concept 773 779	number
T54	Concept 783 792	HLA types
T55	Concept 797 817	amino acid positions
R51	in-context Arg1:T53 Arg2:T54	
T56	Concept 773 779	number
R52	in-context Arg1:T56 Arg2:T55	
T57	Concept 847 857	associated
T58	Concept 861 864	JIA
R53	in-context Arg1:T57 Arg2:T58	
R54	has-property Arg1:T53 Arg2:T57	
R55	has-property Arg1:T56 Arg2:T57	
T59	Concept 866 873	uveitis
R56	in-context Arg1:T57 Arg2:T59	
T60	Concept 897 905	diseases
T61	Concept 886 896	autoimmune
R57	has-property Arg1:T60 Arg2:T61	
R59	in-context Arg1:T57 Arg2:T60	
